Yesterday | ||||
Hot Stocks
|
Endo files Chapter 11 bankruptcy, enters agreement with debt holders »
09:30 08/17/22 08/1709:30 08/17/2209:30
ENDP
Endo
Endo International… Endo International announced that it has entered into a restructuring support agreement with holders of more than a majority of Endo's first lien debt on a sale transaction that would reduce "outstanding indebtedness, address remaining opioid and other litigation-related claims, and best position Endo for the future." Under the RSA, the debtholder group has committed to providing total purchase consideration of approximately $6B in the form of a credit bid, plus assumption of certain liabilities, for substantially all of the company's assets. The transaction contemplates that the purchaser will: Offer employment to all of Endo's active team members; Establish voluntary trusts, to be funded with $550M over 10 years, whereby future proceeds will be set aside for certain opioid claims; and have net funded leverage in an amount no greater than 4.5 times. This "stalking horse" bid will be subject to higher or otherwise better offers, the company said in a statement. To facilitate the sale process and provide an appropriate forum for bringing closure to opioid-related and other uncertainties, Endo and certain of its subsidiaries initiated voluntary prearranged Chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District of New York. Endo's India-based entities are not part of the Chapter 11 proceedings. The company expects to file recognition proceedings in Canada, the United Kingdom, and Australia. Shares of Endo are up 15% to 43c in premarket trading. ShowHide Related Items >><<
|
Monday | ||||
Hot Stocks
|
Paulson buys VMware, exits DiDi in Q2 »
17:16 08/15/22 08/1517:16 08/15/2217:16
VMW
VMware
ironSource
SPDR Gold Shares
Didi Global
Exxon Mobil
Oil Services Holders Trust
Tim SA
Horizon Therapeutics
Bausch Health
Endo
Occidental Petroleum
Pacira
Newmark
BrightSphere
KraneShares CSI China Internet ETF
John Paulson's… John Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of June 30, 2022. The fund's five new buys during the second quarter included, by size of position, VMware (VMW) and IronSource (IS). Paulson exited six positions during the quarter, including by size of previous position SPDR Gold Shares (GLD), DiDi (DIDIY), Exxon Mobil (XOM), VanEck Oil Services ETF (OIH), and TIM SA (TIMB). The fund increased its stake in two holdings, namely Horizon Therapeutics (HZNP) and Bausch Health (BHC). Paulson reduced its stake in four holdings, including by size of previous position Endo (ENDP), Occidental (OXY), Pacira Biosciences (PCRX) and Newmark (NMRK). The fund's top holdings as of June 30, in order of size, were Horizon Therapeutics, Bausch Health, BrightSphere (BSIG), Occidental, and KraneShares CSI China Internet ETF (KWEB). ShowHide Related Items >><<
|
Friday | ||||
Options
|
Largest borrow rate increases among liquid names »
08:45 08/12/22 08/1208:45 08/12/2208:45
WRBY
Warby Parker
eXp World Holdings
Newegg Commerce
Vertex Energy
Cassava Sciences
BioAtla
Avadel Pharmaceuticals
Digital World Acquisition
Endo
Canaan
Latest data shows the… Latest data shows the largest indicative borrow rate increases among liquid option names include: Warby Parker (WRBY) 13.35% +2.28, eXp World Holdings (EXPI) 4.08% +0.90, Newegg Commerce (NEGG) 68.02% +0.75, Vertex Energy (VTNR) 5.67% +0.69, Cassava Sciences (SAVA) 42.09% +0.54, BioAtla (BCAB) 1.40% +0.29, Avadel Pharmaceuticals (AVDL) 12.01% +0.28, Digital World Acquisition Corp (DWAC) 50.81% +0.25, Endo (ENDP) 6.77% +0.20, and Canaan Inc (CAN) 1.22% +0.18. ShowHide Related Items >><<
|
Over a week ago | ||||
Options
|
Largest borrow rate increases among liquid names »
08:45 08/11/22 08/1108:45 08/11/2208:45
ISPO
Inspirato
Microvast
Faraday Future
UP Fintech
Hyliion Holdings
EVgo
Endo
Yellow Corp
Amyris
Carvana
Latest data shows the… Latest data shows the largest indicative borrow rate increases among liquid option names include: Inspirato (ISPO) 67.87% +16.69, Microvast Holdings (MVST) 12.79% +6.37, Faraday Future Intelligent Electric (FFIE) 6.66% +0.82, UP Fintech Holding Ltd (TIGR) 34.99% +0.64, Hyliion Holdings (HYLN) 1.93% +0.43, EVgo (EVGO) 42.02% +0.40, Endo (ENDP) 7.60% +0.33, Yellow Corp (YELL) 3.48% +0.29, Amyris (AMRS) 2.44% +0.28, and Carvana (CVNA) 1.29% +0.25. ShowHide Related Items >><<
| |||
Options
|
Endo options imply 43.5% move in share price post-earnings »
14:34 08/09/22 08/0914:34 08/09/2214:34
ENDP
Endo
Pre-earnings options… Pre-earnings options volume in Endo is 2.4x normal with calls leading puts :. Implied volatility suggests the market is anticipating a move near 43.5%, or 0c, after results are released. Median move over the past eight quarters is 13.5%. ShowHide Related Items >><<
| |||
Hot Stocks
|
Endo expects pre-arranged filing under Chapter 11 'imminently' »
08:55 08/09/22 08/0908:55 08/09/2208:55
ENDP
Endo
As of June 30, 2022, the… As of June 30, 2022, the company had approximately $1.2 billion in unrestricted cash; $8.1 billion of debt; and a net debt to adjusted EBITDA ratio of 5.6. These amounts reflect the company's payment of $35 million to acquire 6 sterile injectable product candidates and a $30 million upfront payment related to a Phase 3 injectable compound for the treatment of osteoarthritis knee pain. Second-quarter 2022 net cash used in operating activities was $133 million compared to $155 million provided by operating activities during the second-quarter 2021. This change was primarily attributable to decreased revenues. The company remains in constructive negotiations with an ad hoc group of first lien creditors, among other parties. In light of the progress to date, the company expects that these negotiations will likely result in a pre-arranged filing under Chapter 11 of the U.S. Bankruptcy Code by Endo International plc and substantially all of its subsidiaries, which could occur imminently. ShowHide Related Items >><<
| |||
Earnings
|
Endo reports Q2 adjusted EPS (3c), consensus (14c) »
08:47 08/09/22 08/0908:47 08/09/2208:47
ENDP
Endo
Reports Q2 revenue… Reports Q2 revenue $569.11M, consensus $529.94M. As of June 30, the Company had approximately $1.2B in unrestricted cash; $8.1B of debt; and a net debt to adjusted EBITDA ratio of 5.6. These amounts reflect the Company's payment of $35M to acquire 6 sterile injectable product candidates and a $30M upfront payment related to a Phase 3 injectable compound for the treatment of osteoarthritis knee pain. ShowHide Related Items >><<
| |||
Options
|
Endo options imply 25.5% move in share price post-earnings »
15:11 08/08/22 08/0815:11 08/08/2215:11
ENDP
Endo
Pre-earnings options… Pre-earnings options volume in Endo is normal with calls leading puts 11:2. Implied volatility suggests the market is anticipating a move near 25.5%, or 0c, after results are released. Median move over the past eight quarters is 13.5%. ShowHide Related Items >><<
| |||
Hot Stocks
|
Buxton Helmsley sends letter to Endo directors relating to financial disclosures »
06:11 07/26/22 07/2606:11 07/26/2206:11
ENDP
Endo
The Buxton Helmsley… The Buxton Helmsley Group, the New York City-based investment advisor to clients with financial interests in Endo International, issued an open letter to directors of the company and its financial auditor, PricewaterhouseCoopers LLP, relating to financial disclosures. Reference Link ShowHide Related Items >><<
|
Over a month ago | ||||
Hot Stocks
|
Tiziana Life Sciences names Matthew Davis, MD, RPh as Chief Medical Officer »
06:04 07/18/22 07/1806:04 07/18/2206:04
TLSA
Tiziana Life Sciences
Endo
Tiziana Life Sciences… Tiziana Life Sciences (TLSA) announces that it has appointed Matthew Davis, MD, RPh as its Chief Medical Officer and Acting Chief Scientific Officer, effective immediately. Dr. Davis will report to Gabriele Cerrone, Executive Chairman and interim CEO of Tiziana. Dr. Davis previously served as Chief Scientific Officer and Chief Medical Officer at Endo Pharmaceuticals (ENDP) where he restructured the R&D department and collaborated to obtain BLA approval for QWO. ShowHide Related Items >><<
|